Literature DB >> 32314705

[High expression of activated CD4+ memory T cells and CD8+ T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].

Wei Li1, Jingyuan Zeng1, Bo Luo1, Yingyu Mao1, Yu Liang1, Wenjing Zhao1, Nan Hu1, Guanfei Chen1, Xiaoli Zheng2.   

Abstract

Objective To study the infiltration pattern of bladder cancer immune cells and explore the relationship between immune cells and tumor prognosis. Methods The bladder cancer transcript data and corresponding clinical data were downloaded from The Cancer Genome Atlas (TCGA). CIBERSORT software deconvolution method was used to calculate the proportions of 22 kinds of immune cells. R software was used to analyze the immune cell infiltration pattern in each clinical stage. The relationship between each immune cell and prognosis was analyzed by Kaplan-Meier survival. Results A total of 433 cases of gene transcript data were downloaded from the TCGA database, including 414 cases of bladder cancer tissues and 19 normal tissues. After the data were corrected, the proportions of immune cells were calculated using CIBERSORT software. Screening was performed, and 146 cases of bladder cancer tissue and 4 cases of normal bladder tissue were obtained. Activated CD4+ memory T cells and CD8+ T cells had the lowest expression and M0 macrophages had the highest expression in clinical stage IV of bladder cancer. The bladder cancer patients with high expression of activated CD4+ memory T cells, CD8+ T cells and low expression of M0 macrophages had beneficial prognosis. Conclusion The bladder cancer patients with high expression of activated CD4+ memory T cells, CD8+ T cells and low expression of M0 macrophages might have better clinical prognosis.

Entities:  

Mesh:

Year:  2020        PMID: 32314705

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  14 in total

1.  Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Mark Farha; Neil K Jairath; Theodore S Lawrence; Issam El Naqa
Journal:  JCO Clin Cancer Inform       Date:  2020-10

2.  [Bipolar androgen therapy followed by immune checkpoint inhibitors in metastatic castration resistant prostate cancer: A report of 4 cases].

Authors:  S J Liu; H M Hou; Z T Lv; X Ding; L Wang; L Zhang; M Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

3.  [Anesthesia management of athletes' operation in Beijing Olympic Winter Games].

Authors:  Z Y Kang; L L Wang; Y Z Han; X Y Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

4.  Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis.

Authors:  Wenjie Li; Mengting Li; Haizhou Wang; Yanan Peng; Shouquan Dong; Yuanyuan Lu; Fan Wang; Fei Xu; Lan Liu; Qiu Zhao
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.

Authors:  Pengju Li; Shihui Hao; Yongkang Ye; Jinhuan Wei; Yiming Tang; Lei Tan; Zhuangyao Liao; Mingxiao Zhang; Jiaying Li; Chengpeng Gui; Jiefei Xiao; Yong Huang; Xu Chen; Jiazheng Cao; Junhang Luo; Wei Chen
Journal:  Front Cell Dev Biol       Date:  2021-03-18

6.  Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.

Authors:  Neil K Jairath; Mark W Farha; Ruple Jairath; Paul W Harms; Lam C Tsoi; Trilokraj Tejasvi
Journal:  Melanoma Manag       Date:  2020-11-02

7.  An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.

Authors:  Facai Zhang; Dechao Feng; Xiaoming Wang; Yiwei Gu; Zhiyong Shen; Yubo Yang; Jiahao Wang; Quliang Zhong; Dengxiong Li; Huan Hu; Ping Han
Journal:  Front Mol Biosci       Date:  2021-12-23

8.  An HDAC9-associated immune-related signature predicts bladder cancer prognosis.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong; Du Shi
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

9.  Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.

Authors:  Facai Zhang; Xiaoming Wang; Yunjin Bai; Huan Hu; Yubo Yang; Jiahao Wang; Yin Tang; Honggui Ma; Dechao Feng; Dengxiong Li; Ping Han
Journal:  Front Genet       Date:  2021-05-26       Impact factor: 4.599

10.  A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.

Authors:  Zijia Tao; Enchong Zhang; Lei Li; Jianyi Zheng; Yiqiao Zhao; Xiaonan Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.